Neuberger Berman Group
STRO icon

Neuberger Berman Group’s Sutro Biopharma STRO Stock Holding History

Neuberger Berman Group’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,675
Closed -$2.14M – 1978
2021
Q4 		$2.14M Sell
14,675
-7,417
-34% -$1.33M ﹤0.01% 1167
2021
Q3 		$4.08M Buy
22,092
+604
+3% +$115K ﹤0.01% 1003
2021
Q2 		$3.99M Buy
21,488
+267
+1% +$52.3K ﹤0.01% 1019
2021
Q1 		$4.83M Buy
21,221
+9,071
+75% +$2.15M ﹤0.01% 954
2020
Q4 		$2.64M Buy
+12,150
New +$2.01M ﹤0.01% 1059

Other funds holding STRO

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Neuberger Berman Group's STRO Position: Q1 2022 in Review

Neuberger Berman Group sold out of Sutro Biopharma (STRO) in Q1 2022, closing a stake of 14,675 shares — an estimated $2.14M sold.

Neuberger Berman Group first reported a position in STRO in Q4 2020 and held it in 5 quarters. The position peaked at $4.83M in Q1 2021. 114 funds tracked by Wall St. Rank hold STRO as of Q1 2022.

  • Neuberger Berman Group reported no remaining Sutro Biopharma position as of Q1 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 14,675 Sutro Biopharma shares in Q1 2022, an estimated $2.14M.
  • Neuberger Berman Group first reported a position in Sutro Biopharma in Q4 2020 and held it in 5 quarters.
  • Neuberger Berman Group's Sutro Biopharma position peaked at $4.83M in Q1 2021.
  • 114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2022.

Based on Neuberger Berman Group's 13F filing for Q1 2022, filed 13 May 2022.